{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:55:25Z","timestamp":1792194925058,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"50","license":[{"start":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T00:00:00Z","timestamp":1179705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T00:00:00Z","timestamp":1179705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2007,11,1]]},"DOI":"10.1038\/sj.onc.1210529","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T07:49:50Z","timestamp":1180079390000},"page":"7158-7162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":273,"title":["Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes"],"prefix":"10.1038","volume":"26","author":[{"given":"P M","family":"Pollock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Gartside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L C","family":"Dejeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cancer Genome Project","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Futreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Trent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J","family":"Goodfellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,21]]},"reference":[{"key":"BF1210529_CR1","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1074\/jbc.M107785200","volume":"277","author":"HR Burgar","year":"2002","unstructured":"Burgar HR, Burns HD, Elsden JL, Lalioti MD, Heath JK . (2002). Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain. J Biol Chem 277: 4018\u20134023.","journal-title":"J Biol Chem"},{"key":"BF1210529_CR2","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1093\/nar\/28.21.4364","volume":"28","author":"M Burset","year":"2000","unstructured":"Burset M, Seledtsov IA, Solovyev VV . (2000). Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res 28: 4364\u20134375.","journal-title":"Nucleic Acids Res"},{"key":"BF1210529_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1073\/pnas.2237184100","volume":"101","author":"JY Cho","year":"2004","unstructured":"Cho JY, Guo C, Torello M, Lunstrum GP, Iwata T, Deng C et al. (2004). Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. Proc Natl Acad Sci USA 101: 609\u2013614.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210529_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ygeno.2004.05.007","volume":"84","author":"A Chong","year":"2004","unstructured":"Chong A, Zhang G, Bajic VB . (2004). Information for the Coordinates of Exons (ICE): a human splice sites database. Genomics 84: 762\u2013766.","journal-title":"Genomics"},{"key":"BF1210529_CR5","first-page":"2347","volume":"54","author":"LI Gold","year":"1994","unstructured":"Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactigal L et al. (1994). Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 54: 2347\u20132358.","journal-title":"Cancer Res"},{"key":"BF1210529_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature05610","volume":"446","author":"C Greenman","year":"2007","unstructured":"Greenman C, Stephens P, Smith R, Dalgliesh G, Hunter C, Bignell G et al. (2007). Patterns of Somatic mutation in cancer genomes. Nature 446: 153\u2013158.","journal-title":"Nature"},{"key":"BF1210529_CR7","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1073\/pnas.121183798","volume":"98","author":"OA Ibrahimi","year":"2001","unstructured":"Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M . (2001). Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci USA 98: 7182\u20137187.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210529_CR8","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/hmg\/ddh235","volume":"13","author":"OA Ibrahimi","year":"2004","unstructured":"Ibrahimi OA, Zhang F, Eliseenkova AV, Itoh N, Linhardt RJ, Mohammadi M . (2004). Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet 13: 2313\u20132324.","journal-title":"Hum Mol Genet"},{"key":"BF1210529_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C : et al. (2006). Cancer statistics, 2006. CA Cancer J Clin 56: 106\u2013130.","journal-title":"CA Cancer J Clin"},{"key":"BF1210529_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","volume":"16","author":"M Mohammadi","year":"2005","unstructured":"Mohammadi M, Olsen SK, Ibrahimi OA . (2005). Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 16: 107\u2013137.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF1210529_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/molehr\/7.1.65","volume":"7","author":"B Moller","year":"2001","unstructured":"Moller B, Rasmussen C, Lindblom B, Olovsson M . (2001). Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod 7: 65\u201372.","journal-title":"Mol Hum Reprod"},{"key":"BF1210529_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","volume":"20","author":"E Monsonego-Ornan","year":"2000","unstructured":"Monsonego-Ornan E, Adar R, Feferman T, Segev O, Yayon A . (2000). The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol 20: 516\u2013522.","journal-title":"Mol Cell Biol"},{"key":"BF1210529_CR13","first-page":"459","volume":"4","author":"JC Obel","year":"2006","unstructured":"Obel JC, Friberg G, Fleming GF . (2006). Chemotherapy in endometrial cancer. Clin Adv Hematol Oncol 4: 459\u2013468.","journal-title":"Clin Adv Hematol Oncol"},{"key":"BF1210529_CR14","doi-asserted-by":"crossref","unstructured":"Ornitz DM, Itoh N . (2001). Fibroblast growth factors. Genome Biol 2: Reviews3005.1\u2013reviews3005.12.","DOI":"10.1186\/gb-2001-2-3-reviews3005"},{"key":"BF1210529_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","volume":"14","author":"MR Passos-Bueno","year":"1999","unstructured":"Passos-Bueno MR, Wilcox WR, Jabs EW, Sertie AL, Alonso LG, Kitoh H . (1999). Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat 14: 115\u2013125.","journal-title":"Hum Mutat"},{"key":"BF1210529_CR16","first-page":"389","volume":"77","author":"RK Sangha","year":"1997","unstructured":"Sangha RK, Li XF, Shams M, Ahmed A . (1997). Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia. Lab Invest 77: 389\u2013402.","journal-title":"Lab Invest"},{"key":"BF1210529_CR17","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1210\/endo.143.7.8900","volume":"143","author":"SJ Tsai","year":"2002","unstructured":"Tsai SJ, Wu MH, Chen HM, Chuang PC, Wing LY . (2002). Fibroblast growth factor-9 is an endometrial stromal growth factor. Endocrinology 143: 2715\u20132721.","journal-title":"Endocrinology"},{"key":"BF1210529_CR18","first-page":"1265","volume":"61","author":"BW van Rhijn","year":"2001","unstructured":"van Rhijn BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC . (2001). The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 61: 1265\u20131268.","journal-title":"Cancer Res"},{"key":"BF1210529_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cytogfr.2005.03.001","volume":"16","author":"AO Wilkie","year":"2005","unstructured":"Wilkie AO . (2005). Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16: 187\u2013203.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF1210529_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ajmg.10775","volume":"112","author":"AO Wilkie","year":"2002","unstructured":"Wilkie AO, Patey SJ, Kan SH, van den Ouweland AM, Hamel BC . (2002). FGFs, their receptors, and human limb malformations: clinical and molecular correlations. Am J Med Genet 112: 266\u2013278.","journal-title":"Am J Med Genet"},{"key":"BF1210529_CR21","doi-asserted-by":"publisher","first-page":"14536","DOI":"10.1073\/pnas.97.26.14536","volume":"97","author":"K Yu","year":"2000","unstructured":"Yu K, Herr AB, Waksman G, Ornitz DM . (2000). Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci USA 97: 14536\u201314541.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210529_CR22","doi-asserted-by":"publisher","first-page":"15694","DOI":"10.1074\/jbc.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM . (2006). Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 281: 15694\u201315700.","journal-title":"J Biol Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1210529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210529","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:38:57Z","timestamp":1647945537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1210529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,21]]},"references-count":22,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2007,11,1]]}},"alternative-id":["BF1210529"],"URL":"https:\/\/doi.org\/10.1038\/sj.onc.1210529","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,21]]},"assertion":[{"value":"1 February 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}